Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0,1
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0,1 <100
General Information
Version
20
Revision date
2026-07-21
Product name
4UV64Series
Product Synonyms
None
Emergency telephone
+354 543 2222
Icons in SDS
Company Information
company name
HP Inc. UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
sustainability@hp.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Health hazards
Skin sensitization Category 1 H317 - May cause an allergic skin reaction
Contains
1,2-Benzisothiazolin-3-one (Benzisothiazolinone), 2-Methyl-2h-isothiazol-3-one (Methylisothiazolinone)
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction.
Prevention
P280 Wear protective gloves/protective clothing/eye protection/face protection. P261 Avoid breathing dust/fume/mist/vapors. P272 Contaminated work clothing should not be allowed out of the workplace.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
Incorporates biocides: Benzisothiazolinone and Methylisothiazolinone.
2.3 Other hazards
Complete toxicity data are not available for this specific formulation. Potential routes of overexposure to this product are skin and eye contact. Inhalation of vapor and ingestion are not expected to be significant routes of exposure for this product under normal use conditions. Endocrine disrupting properties (Toxicity/Ecotoxicity): This mixture does not contain known components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels above possible trace contaminate levels.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended Health hazards Skin sensitization Category 1 H317 - May cause an allergic skin reaction.
